CD8A and infection: A relatively high breadth in the first month after infection, averaged over many patients (~85% of the maximum), may arise from the mixture of patients in the early and late stages of acute infection; it may be expected that patients with early acute infection have few CD8+ T-cell responses, whereas patients with late acute infection have many CD8+ T-cell responses.